Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 2
1974 2
1977 1
1978 1
1980 1
1982 2
1983 2
1984 2
1985 2
1986 1
1987 1
1988 3
1989 5
1990 3
1991 1
1992 2
1993 1
1994 2
1995 1
1997 3
1998 3
2000 1
2004 1
2009 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, Migasena S, Kitayaporn D, Pitisuttitham P, Matthews T, Schwartz DH, Berman PW. Francis DP, et al. Among authors: migasena s. AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S325-31. AIDS Res Hum Retroviruses. 1998. PMID: 9814961 Review.
ELISA for immunodiagnosis of human gnathostomiasis.
Suntharasamai P, Desakorn V, Migasena S, Bunnag D, Harinasuta T. Suntharasamai P, et al. Among authors: migasena s. Southeast Asian J Trop Med Public Health. 1985 Jun;16(2):274-9. Southeast Asian J Trop Med Public Health. 1985. PMID: 4071200
SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand.
Migasena S, Heppner DG, Kyle DE, Chongsuphajaisiddhi T, Gordon DM, Suntharasamai P, Permpanich B, Brockman A, Pitiuttutham P, Wongsrichanalai C, Srisuriya P, Phonrat B, Pavanand K, Viravan C, Ballou WR. Migasena S, et al. Acta Trop. 1997 Sep 30;67(3):215-27. doi: 10.1016/s0001-706x(97)00061-2. Acta Trop. 1997. PMID: 9241386 Clinical Trial.
Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.
Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai LO, Hirunras K, Kitayaporn D, Kaewkangwal J, Migasena S, Sheppard HW, Li E, Chernow M, Peterson ML, Shibata R, Heyward WL, Francis DP. Pitisuttithum P, et al. Among authors: migasena s. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1160-5. doi: 10.1097/01.qai.0000136091.72955.4b. J Acquir Immune Defic Syndr. 2004. PMID: 15319676 Clinical Trial.
45 results